BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca ...Middle East

Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's drug discovery platform and selected for AstraZeneca's drug development portfolio A total of three targets have been selected for portfolio-entry in the collaboration to date, with the potential to...

Hence then, the article about benevolentai achieves third milestone in its ai enabled drug discovery collaboration with astrazeneca was published today ( Tuesday 17/05/2022 - 08:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca )

Also on site :

• India Adds a new Nuke To Its Fleet
• Middle East Oil Pricing Is Cracking Under Pressure
• EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion